Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Axalbion Logo
Axalbion Growth Score
81
CB Rank
875781
Heat Score
57
Axalbion is a pharmaceutical company that develops and eveluates RPM8 agonists
Founded
obfuscation
Private Lausanne, Vaud, Switzerland axalbion.com
Biotechnology
Health Care
Overview

Axalbion
Growth Score
81
Heat Score
57

Growth Score81
-6 pts
in past quarter
Heat Score 57
-18 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Axalbion

CB Rank
875781
Axalbion is a pharmaceutical company that develops and eveluates RPM8 agonists
Founded
obfuscation
Private Lausanne, Vaud, Switzerland axalbion.com
Biotechnology
Health Care

Key People

Details

Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AX-8
AX-8 is a TRPM8 agonist developed for topical treatment of chronic cough and dry eye syndrome by modulating sensory nerve reflexes to reduce symptoms.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Employee Profiles 1

Employee Profiles

News

News and Press

News•Feb 14, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 29, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 29, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

193

Interest Signals

TopicSurge Score
Live Science Logo
Live Science
80

Active Website Tech Count

5Axalbion is actively using 5 technologies for its website, according to BuiltWith. These include Google Maps, Google Maps API, and  Google Maps for Work.

Total IP

6The intellectual property of Axalbion includes 6 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Axalbion's headquarters? Axalbion is located in Lausanne, Vaud, Switzerland.Who are Axalbion's competitors? Alternatives and possible competitors to Axalbion may include Sanofi, Amgen, and  Merck.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3120884 1)
|